首页> 外国专利> SUBSTITUTED BIS-DI-ALKYL (OR CYCLIC) AMINO ALKOXY PHENANTHRENE (OR 10-OXA-O 10-AZA-PHENANTHENE) DERIV ATIVES

SUBSTITUTED BIS-DI-ALKYL (OR CYCLIC) AMINO ALKOXY PHENANTHRENE (OR 10-OXA-O 10-AZA-PHENANTHENE) DERIV ATIVES

机译:取代的BIS- [二烷基(或环)氨基]醇菲(或10-氧杂-O 10-氮杂-菲)衍生物

摘要

1420377 Bis basic alkoxy tricyclic compounds RICHARDSON-MERRELL Inc 17 Dec 1973 [21 Dec 1972] 58266/73 Heading C2C Novel compounds of Formulae I and II wherein n is an integer of from 2 to 6; R and R 1 are each hydrogen, lower alkyl having from 1 to 6 carbon atoms, cycloalkyl having from 3 to 6 carbon atoms, alkenyl having from 3 to 6 carbon atoms in which the unsaturation is in a position other than the 1-position of the alkenyl group, and when R and R 1 are taken together with the nitrogen atom to which they are attached represent the pyrrolidinyl, piperidino or morpholino radical; Z is oxygen, imino and methylene; Y is nitrogen or methylidene; R 2 is selected from the group consisting of hydrogen or lower alkyl having from 1 to 4 carbon atoms; and the pharmaceutically acceptable acid addition salts thereof are prepared by one of the following methods, (a) those of Formula IIA wherein R 3 is alkyl or H are prepared by reactng a compound of Formula III with a diazo compound R 3 N 2 ; (b) those of Formula VI are prepared by reacting a fluorenone of Formula III above with hydrazoic acid; (c) those of Formula X are prepared by reacting a compound of Formula VIII with the base HNRR 1 ; and (d) compounds with an ether group on the central ring are prepared by alkylation of the enol form of the ketone of Formula I wherein Z is methylene or imino. Intermediates of Formula VIII above are prepared by action of hydrogen peroxide or a per acid on a compound of Formula VII wherein Hal denotes Cl, Br or I. Compounds of Formula III above are prepared by reaction of 2,7-dihydroxyfluoren-9-one with a compound RR 1 N(CH 2 ) n Cl. Anti-viral compositions in conventional forms for oral, parenteral and topical administration comprise an above novel compound and a carrier or diluent.
机译:1420377双碱性烷氧基三环化合物RICHARDSON-MERRELL Inc 1973年12月17日[1972年12月21日]标题C2C新型的式I和II的化合物,其中n为2至6的整数; R和R 1各自为氢,具有1至6个碳原子的低级烷基,具有3至6个碳原子的环烷基,具有3至6个碳原子的烯基,其中不饱和基团位于除1的C 1-位以外的位置。当R和R 1与它们所连接的氮原子合在一起时,代表烯基,包括吡咯烷基,哌啶子基或吗啉代基。 Z为氧,亚氨基和亚甲基; Y是氮或亚甲基; R 2选自氢或具有1-4个碳原子的低级烷基;以及其药学上可接受的酸加成盐是通过以下方法之一制备的:(a)通过使式III化合物与重氮化合物R 3 N 2反应制备式IIA(其中R 3为烷基或H)的化合物; (b)通过使以上式III的芴酮与肼酸反应来制备式VI的那些; (c)通过使式VIII的化合物与碱HNRR 1反应制备式X的化合物; (d)在中心环上具有醚基的化合物是通过将Z为亚甲基或亚氨基的式I的酮的烯醇式烷基化而制备的。上述式VIII的中间体是通过过氧化氢或过酸作用于式VII化合物(其中Hal表示Cl,Br或I)制备的。上述式III化合物通过2,7-二羟基芴-9-化合物RR 1 N(CH 2)n Cl。用于口服,肠胃外和局部给药的常规形式的抗病毒组合物包含上述新型化合物和载体或稀释剂。

著录项

  • 公开/公告号IL43674B

    专利类型

  • 公开/公告日1977-02-28

    原文格式PDF

  • 申请/专利权人 RICHARDSON-MERRELL INC.;

    申请/专利号IL43674

  • 发明设计人

    申请日1973-11-21

  • 分类号A61K27/00;C07C93/06;C07D7/18;C07D39/02;

  • 国家 IL

  • 入库时间 2022-08-23 00:51:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号